Timolol Eyedrops Evaluated for Acute Migraine Treatment
During the study, 50 migraine patients randomly received either topically applied timolol maleate ophthalmic solution, 0.5%, or placebo eyedrops.
All articles by Cassandra Pardini, PharmD
Vaccination Linked to Reduced Alzheimer Disease Risk
At AAIC 2020, 2 presentations separately discussed observing a reduced risk of AD in patients who received the influenza and pneumonia vaccines.
Supplements With Undeclared Active Ingredients Pose Substantial Health Risk
A recent Morbidity and Mortality Weekly Report highlights the risks associated with use of over-the-counter products containing undeclared prescription ingredients as well as the importance of collaboration between various health departments and systems to ensure a prompt response to an outbreak.
Penicillin-, Ciprofloxacin-Resistant Meningococci Detected in United States
The CDC has reported observing a significant increase in the number of meningococcal disease cases with isolates containing a blaROB-1 β-lactamase enzyme gene, conferring resistance to penicillin antibiotics and, in some cases, ciprofloxacin as well.
Evidence Supporting Use of Compounded Topical Pain Creams Limited
Due to a lack of evidence on the safety of the ingredients used in topical pain cream, caution should be exercised when prescribing these preparations.
Early Metformin Initiation Does Not Appear to Reduce Risk for Dementia
Previous research has suggested that treatment with metformin may potentially lower the risk of dementia, however whether the timing of treatment impacts this result remains unclear.
Acute Neurologic Deficit Linked to Salicylate Toxicity
Due to her neurologic presentation, age, and past medical history, stroke was initially considered.
Guidance Issued on Managing Pain During Public Health Crises
In order to provide national guidance addressing issues surrounding pain management practices, an expert panel was convened to provide a framework for pain practitioners and institutions.
Novel Meloxicam/Rizatriptan Combo Superior to Placebo in Migraine Trial
Treatment with AXS-07, an investigational therapy being developed by Axsome Therapeutics, substantially reduced migraine pain and significantly prevented the progression of migraine pain intensity, according to results of the phase 3 INTERCEPT trial.
Anticholinergic Medications for Overactive Bladder May Increase Risk for Dementia
Among patients with OAB, anticholinergic medication use appears to be associated with an increased risk of new onset dementia when compared with beta-3 agonist use, according to the findings of a retrospective population-based cohort study.
-
Loading...
-
Loading...
Next post in Alzheimer's Disease and Dementia
